OSIMERTINIB INTENDED FOR USE IN THE TREATMENT OF NON-SMALL CELL LUNG CANCER

MA51823AUndetermined Publication Date: 2021-05-19ASTRAZENECA AB

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: MA51823
Authority / Receiving Office: MA · MA
Patent Type: Applications
Current Assignee / Owner
Priority Date: 2018-02-12
Filing Date: 2019-02-11
Publication Date: 2021-05-19

Application Information

Patent Timeline

12 Feb 2018

Priority

11 Feb 2019

Application

MA51823

19 May 2021

Publication

MA51823A

IPC: A61K31/337; A61K31/475; A61K31/506; A61K31/519; A61K31/555; A61K31/7048; A61K31/7068; A61K33/243; A61P35/00

CPC: A61K31/506; A61K33/243; A61K31/555; A61K45/06; A61P35/00; A61K2300/00; A61K31/337; A61K31/475

Inventors: NASH Anthony Francis Patrick

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Need to check novelty before this filing date? Find Prior Art

No text content released.